COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

How the early months of the COVID-19 pandemic impacted 6-month outcomes for heart attack patients

Enough time has now passed since the COVID-19 pandemic began that researchers are starting to learn more and more about how, exactly, it affected cardiovascular care.

ACC.21 goes completely virtual due to continued COVID-19, travel concerns

The American College of Cardiology has announced that its 2021 annual meeting, ACC.21, will now be entirely virtual. The meeting is still scheduled for May 15-17, 2021.

Thumbnail

A month after discharge, heart damage still present in 54% of COVID-19 patients with raised troponin levels

“Importantly, the pattern of damage to the heart was variable, suggesting that the heart is at risk of different types of injury,” one researcher said. 

Heart failure medication may offer relief for patients with COVID-related POTS

Overall, researchers found that ivabradine was a “safe and effective” POTS treatment associated with making significant improvements to patient heart rates and quality of life.

American College of Cardiology calls for high-risk heart disease patients to be prioritized for COVID-19 vaccination

According to the new recommendation, patients with advanced cardiovascular disease are at an especially high risk of COVID-related complications and need to be vaccinated as quickly as possible. 

CV Summit Virtual 2021: How COVID-19 has led to lasting changes in cardiovascular care

Some COVID-driven changes will likely remain in place for years to come, according to a presentation at CV Summit Virtual 2021.

Thumbnail

‘The future of digital health’: Apple Watch uses heart rates to ID COVID-19

A team of Mount Sinai specialists published the study, emphasizing the potential of these technologies to improve patient care in a significant way.

Thumbnail

Can COVID-19 lead to bioprosthetic valve thrombosis? What specialists need to know

“To our knowledge, this is the first report of prosthetic aortic valve thrombosis associated with COVID-19 infection,” the authors wrote.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.